Search clinical trials for: nonsegmental vitiligo

Total 251 results

Hospital Universitario Dr. Jose E. Gonzalez

Completed

Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo

Autoimmune Diseases | Vitiligo | Vitiligo, Generalized | Autoimmune | Autoimmune Disease Skin

Mexico
University Hospital, Ghent
Novartis

Completed

Secukinumab in Active Non-segmental Vitiligo

Vitiligo | Secukinumab

Belgium
Cairo University

Suspended

Autologous Cellular Graft in Surgical Treatment of Vitiligo

Vitiligo, Generalized

Egypt
Momentum Data
Pfizer; University of Oxford; University of Surrey

Completed

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Multiple Sclerosis | Pneumonia | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Anxiety Disorders | Psoriasis | Asthma | Type 1 Diabetes | Graves Disease | Celiac Disease | Allergic Rhinitis | Urinary Tract Infections | Crohn Disease | Influenza | Ulcerative Colitis | Herpes Zoster | Herpes Simplex | Atopic Dermatitis | V... and other conditions

United Kingdom
Momentum Data
Pfizer

Completed

Mental Health Associations With Vitiligo

Anxiety Disorders | Suicide, Attempted | Vitiligo | Self-Harm, Deliberate | Substance Abuse | Social Phobia | Overdose | Adjustment Disorders | Depressive Episode | Recurrent Depressive Disorder | Parasuicide

United Kingdom
University Hospital, Ghent

Completed

Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) (Koebner)

Vitiligo

Belgium
Incyte Corporation

Completed

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Vitiligo

United States
Combined Military Hospital Abbottabad

Completed

Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo

Vitiligo

Pakistan
Incyte Corporation

Completed

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Non-segmental Vitiligo

United States, Canada, Italy, France, Germany, Spain, Poland, Bulgaria, Netherlands
Incyte Corporation

Completed

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

Non-segmental Vitiligo

United States, Spain, Canada, France, Poland, Bulgaria, Germany, Italy
Jordan University of Science and Technology

Active, not recruiting

Phototherapy Combination With Topicals in Vitiligo (NBUVB)

Vitiligo, Generalized

Jordan
Centre Hospitalier Universitaire de Nice

Completed

Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. (Vitisod)

Vitiligo

France
Centre Hospitalier Universitaire de Nice

Completed

Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin (Dermabrasion)

Vitiligo - Macular Depigmentation

France
Universidad Autonoma de San Luis Potosí

Completed

Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo

Vitiligo

Mexico
Cairo University

Completed

Effect of NB-UVB on the Tissue Level of IL 15 and IL-15Rα in Active Non Segmental Vitiligo Cases.

Active Non Segmental Vitiligo

Egypt
Arcutis Biotherapeutics, Inc.

Terminated

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

Vitiligo

United States
Medical University of South Carolina

Completed

Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment

Vitiligo

United States
Galderma R&D

Completed

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

Melasma

United States
Cairo University

Completed

Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo

Metabolic Syndrome | Vitiligo

Egypt
Reistone Biopharma Company Limited

Terminated

Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

Vitiligo

China
Hallym University Kangnam Sacred Heart Hospital

Completed

Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency

Vitamin D Deficiency | Vitiligo

Korea, Republic of
Pfizer

Completed

A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects

Active Non-segmental Vitiligo

Spain, United States, Korea, Republic of, Taiwan, Canada, Australia, Germany, Japan, Belgium, Italy
Kasr El Aini Hospital

Active, not recruiting

E-cadherin and Integrin Alpha v Beta 1 in Vitiligo

Vitiligo

Egypt
Henry Ford Health System

Terminated

Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters

Vitiligo

United States
Pfizer

Completed

PF-06651600 for the Treatment of Alopecia Areata (ALLEGRO-2b/3)

Alopecia Areata

China, United States, Spain, Korea, Republic of, Taiwan, Canada, Australia, Germany, Czechia, Poland, Hungary, Japan, United Kingdom, Argentina, Chile, Colombia, Mexico, Russian Federation
Henry Ford Health System

Terminated

Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo

Generalized Vitiligo

United States
Kasr El Aini Hospital

Active, not recruiting

Resident Memory T Cells in Vitiligo

Vitiligo

Egypt
NYU Langone Health

Completed

Stress Response Pathways in Vitiligo

Vitiligo

United States
Pfizer

Completed

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

Skin Diseases | Immune System Diseases | Hypersensitivity | Hypersensitivity, Immediate | Genetic Diseases, Inborn | Skin Diseases, Genetic | Dermatitis | Eczema | Skin Diseases, Eczematous | Dermatitis, Atopic

United States, Spain, Taiwan, Germany, Canada, China, Poland, Belgium, Serbia, Brazil, Russian Federation, Israel, Latvia, Italy, Romania, Mexico, Argentina, Bulgaria, Chile, Netherlands, Slovakia
Cairo University

Completed

Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo

Vitiligo
University Hospital, Bordeaux

Completed

Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC (VITAC)

Vitiligo

France
Central Hospital, Nancy, France

Enrolling by invitation

Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up (AADT1D)

Autoimmune Diseases | Type 1 Diabetes | Graves Disease | Celiac Disease | Vitiligo | Hashimoto Disease | Addison Disease

France
xjpfW
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; First Hospital... and other collaborators

Completed

Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo

Vitiligo

China
Novartis Pharmaceuticals

Completed

A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers

Renal Impairment

Germany, South Africa
Aclaris Therapeutics, Inc.

Completed

A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

Vitiligo

United States
Dermavant Sciences GmbH

Completed

Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo

Vitiligo

United States
Mayo Clinic

Completed

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Multiple Sclerosis | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Uveitis | Vasculitis | Psoriasis | Graves Disease | Systemic Sclerosis | Celiac Disease | Crohn Disease | Type 1 Diabetes Mellitus | Myasthenia Gravis | Ulcerative Colitis | Dermatomyositis | Polymyositis | Vitiligo | Hepatitis, Autoimmune | Polymyalgia... and other conditions

United States
Cassiopea SpA

Completed

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)

Acne Vulgaris

United States, Georgia, Ukraine
Assiut University

Unknown

Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo

Vitiligo | Excimer Laser | Fractional CO2 Laser
Yonsei University

Completed

The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity

Vitiligo

Korea, Republic of
Nicolaus Copernicus University

Completed

The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo (EVRAAS)

Non-segmental Vitiligo

Poland
Tufts Medical Center

Completed

Topical Ruxolitinib for the Treatment of Vitiligo

Vitiligo

United States
The Catholic University of Korea

Completed

PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation

Vitiligo

Korea, Republic of
Peking University People's Hospital

Completed

Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo

Vitiligo

China
Assiut University

Unknown

Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo (PRP)

Vitiligo
University of British Columbia

Unknown

Efficacy of Red Light in the Treatment of Pigmentary Disorders

Vitiligo | Melasma | Lichen Planus Pigmentosus

Canada
Shin Kong Wu Ho-Su Memorial Hospital

Completed

The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients

Brief Description of Focus of Study Instead

Taiwan
Centre Hospitalier Universitaire de Nice
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo (INNATEvitiligo)

Vitiligo

France
Centre Hospitalier Universitaire de Nice

Completed

Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO (Rapid Vitiligo)

Vitiligo

France
Laboratoire Dermatologique ACM

Unknown

Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo

Vitiligo

Tunisia

Search clinical trials for: nonsegmental vitiligo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations